Article

Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura.

Centre for Neuroregeneration, University of Edinburgh, Edinburgh, United Kingdom.
Annals of Neurology (Impact Factor: 11.91). 10/2012; 72(4):559-63. DOI: 10.1002/ana.23653
Source: PubMed

ABSTRACT Migraine with aura is a severe debilitating neurological disorder with few relatively specific therapeutic options.
We used amiloride, a blocker of epithelial sodium channels, to evaluate its pharmacological potential and explored the biology of a potential mechanism of action in well-established experimental models.
Amiloride was shown to block cortical spreading depression, the experimental correlate of aura, and inhibited trigeminal activation in in vivo migraine models, via an acid-sensing ion channel 1 mechanism. Remarkably, amiloride then demonstrated good clinical efficacy in a small open-labeled pilot study of patients, reducing aura and headache symptoms in 4 of 7 patients with otherwise intractable aura.
The observations here identify an entirely novel treatment strategy for migraine. ANN NEUROL 2012;72:559-563.

1 Bookmark
 · 
206 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Migraine is a common, complex brain disorder whose biology is becoming better understood. Despite being the most disabling of the neurological disorders on a worldwide basis, headache disorders broadly, and migraine in particular, have poor research funding and a limited academic base. Given a modicum of investment, new targets, such as calcitonin gene‐related peptide–based mechanisms, and entirely novel neuromodulation approaches illustrate that much can be done to improve patient care. Genetics and neuroimaging combined with excellent clinical phenotyping and translational neuroscience approaches are set to transform life for a cohort of patients with these common brain disorders. Ann Neurol 2013;74:423–434
    Annals of Neurology 01/2013; 74(3). · 11.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Punctuated episodes of spreading depolarizations erupt in the brain, encumbering tissue structure and function, and raising fascinating unanswered questions concerning their initiation and propagation. Linked to migraine aura and headache, cortical spreading depression contributes to the morbidity in the world's migraine with aura population. Even more ominously, erupting spreading depolarizations accelerate tissue damage during brain injury. The once-held view that spreading depolarizations may not exist in the human brain has changed, largely because of the discovery of migraine genes that confer cortical spreading depression susceptibility, the application of sophisticated imaging tools and efforts to interrogate their impact in the acutely injured human brain.
    Nature reviews. Neuroscience 05/2014; 15(6):379-393. · 31.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Migraine is one of the most common neurological disorders. Despite its prevalence, the basic physiology of the molecules and mechanisms that contribute to migraine headache is still poorly understood, making the discovery of more effective treatments extremely difficult. The consistent presence of head-specific pain during migraine suggests an important role for activation of the peripheral nociceptors localized to the head. Accordingly, this review will cover the current understanding of the biological mechanisms leading to episodic activation and sensitization of the trigeminovascular pain pathway, focusing on recent advances regarding activation and modulation of ion channels.
    Headache The Journal of Head and Face Pain 04/2014; 54(4):619-39. · 2.94 Impact Factor

Full-text

Download
106 Downloads
Available from
May 31, 2014